FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2020/11/029331 [Registered on: 24/11/2020] Trial Registered Prospectively
Last Modified On: 18/11/2020
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Triphala Ghrita tulle (Vikeshika) and betadine tulle (Vikeshika) dressing in the management of Dushta Vrana (Infected wound). 
Scientific Title of Study   Randomised comparative clinical study to evaluate the efficacy of Triphala Ghrita tulle (Vikeshika) and betadine tulle (Vikeshika) dressing in the management of Dushta Vrana (Infected wound). 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
Nil   NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Amrita Bhausaheb Dandekar 
Designation  PG student Surgery Department 
Affiliation  Sumatibhai Shah ayurved mahavidyalya hadapasar pune  
Address  OPD no 3 ,Shalyatantra Department, Sane Guruji Hospital Malwadi Hadapsar Pune
Malwadi Hadapsar Pune
Pune
MAHARASHTRA
411028
India 
Phone  8668582524  
Fax    
Email  amrutadandekar2524@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Rashmi Kale 
Designation  Professor 
Affiliation  Sumatibhai shah ayurved mahavidyalya malwadi hadapasar pune  
Address  OPD no 3 Sane Guruji Hospital Malwadi Hadapsar Pune
Malwadi Hadapsar Pune
Pune
MAHARASHTRA
411028
India 
Phone  9822244893  
Fax    
Email  drrakale@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Amrita Bhausaheb Dandekar 
Designation  PG student Surgery Department 
Affiliation  Sumatibhai Shah ayurved mahavidyalya hadapasar pune  
Address  OPD no 3 Shalyatantra Department, Sane Guruji Hospital Malwadi Hadapsar Pune
Malwadi Hadapsar Pune
Pune
MAHARASHTRA
411028
India 
Phone  8668582524  
Fax    
Email  amrutadandekar2524@gmail.com  
 
Source of Monetary or Material Support  
OPD no 3, Shalyatantra Department, Sane Guruji Hospital Malwadi Hadapsar Pune28 
 
Primary Sponsor  
Name  Amrita Bhausaheb Dandekar 
Address  OPD no 3 Sane Guruji Hospital Malwadi Hadapsar Pune 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
Nil  Nil 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Amrita Bhausaheb Dandekar  Sane Guruji hospital Malwadi hadapasar pune   OPD no 3 Shalyatantra Department,Sane Guruji Hospital Malwadi Hadapsar Pune
Pune
MAHARASHTRA 
8668582524

amrutadandekar2524@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committe , SSAM hadapasar pune  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: T07||Unspecified multiple injuries,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Povidine Iodine  Povidine Iodine 
Intervention  Randomised comparative clinical study to evaluate the efficacy of Triphala Ghrita tulle (Vikeshika) and betadine tulle (Vikeshika) dressing in the management of Dushta Vrana (Infected wound).  Infected wound is one of the major contributors to morbidity and mortality. World wise annually 2 million cases concern annually worldwide.(6) Each year it is to estimate that infected wound develops in 2%-5% of the 16 million patients undergoing surgical procedure.(7) There is infection of wound is difficult to define and no clear rules can be given to distinguish from contamination and colonisation.(8) This study plans to assess efficacy of Triphala Ghrita tulle (Vikeshika) in the management of Dushta Vrana. Sample size - 60 route of administration - local application Dose- as per wound site Duration- 15 days  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patient having infected wound.
Wound size 3 cm x 3 cm to 15 cm x 15 cm.
Infected wound due to trauma and accident.
Post-operative all infected wound
Age group 18 yrs to 60 yrs.
Gangrenous wound
Diabetic infected wound 
 
ExclusionCriteria 
Details  Neoplastic ulcer
Other associated disorders e.g. gout, renal failure
Liver failure; Bed sores
Varicose ulcer
HIV & and immunocompromised patients  
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Triphala Ghrita tulle (Vikeshika) is effective in the management of Dushtavrana.
(Infected wound) 
2 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
Triphala Ghrita tulle (Vikeshika) is not effective in the management of
Dushtavrana(Infected wound)
There is significant difference in the efficacy of Triphala Ghrita tulle
(Vikeshika) and Betadine tulle (Vikeshika) in the management of Dushtavrana 
1 yr 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 1/ Phase 2 
Date of First Enrollment (India)   02/12/2020 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   Nil 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Title of study - Randomised comparative clinical study to evaluate the efficacy of Triphala Ghrita tulle (Vikeshika) and betadine tulle (Vikeshika) dressing in the management of Dushta Vrana (Infected wound).
Sample size - 60
Inclusion criteria
Patient having infected wound.
 Wound size 3 cm x 3 cm to 15 cm x 15 cm. 
 Infected wound due to trauma and accident. 
 Post-operative all infected wound 
 Age group 18 yrs to 60 yrs. 
 Gangrenous wound 
Diabetic infected wound 
Exclusion Criteria 
 Neoplastic ulcer 
Other associated disorders e.g. gout, renal failure 
 Liver failure; Bed sores 
 Varicose ulcer 
 HIV & and immunocompromised patients 
Duration -15 days
Administration - local application
Dose - as per wound size
 
Close